These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12052221)

  • 1. Genomics and the prospects for the discovery of new targets for antibacterial and antifungal agents.
    Isaacson RE
    Curr Pharm Des; 2002; 8(13):1091-8. PubMed ID: 12052221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach.
    Chalker AF; Lunsford RD
    Pharmacol Ther; 2002 Jul; 95(1):1-20. PubMed ID: 12163125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of genomics in antibacterial target discovery.
    Buysse JM
    Curr Med Chem; 2001 Dec; 8(14):1713-26. PubMed ID: 11562290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antibacterials: a genomics approach to drug discovery.
    Chan PF; Macarron R; Payne DJ; Zalacain M; Holmes DJ
    Curr Drug Targets Infect Disord; 2002 Dec; 2(4):291-308. PubMed ID: 12570737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets and assays for discovering novel antibacterial agents.
    Donadio S; Carrano L; Brandi L; Serina S; Soffientini A; Raimondi E; Montanini N; Sosio M; Gualerzi CO
    J Biotechnol; 2002 Nov; 99(3):175-85. PubMed ID: 12385707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using bacterial genomes and essential genes for the development of new antibiotics.
    Fields FR; Lee SW; McConnell MJ
    Biochem Pharmacol; 2017 Jun; 134():74-86. PubMed ID: 27940263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery.
    Haselbeck R; Wall D; Jiang B; Ketela T; Zyskind J; Bussey H; Foulkes JG; Roemer T
    Curr Pharm Des; 2002; 8(13):1155-72. PubMed ID: 12052225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic pathways to antifungal discovery.
    Monk BC; Cannon RD
    Curr Drug Targets Infect Disord; 2002 Dec; 2(4):309-29. PubMed ID: 12570738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the power of the genome in the search for new antibiotics.
    Rosamond J; Allsop A
    Science; 2000 Mar; 287(5460):1973-6. PubMed ID: 10720317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery.
    Glass JI; Belanger AE; Robertson GT
    Curr Opin Microbiol; 2002 Jun; 5(3):338-42. PubMed ID: 12057692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D
    Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of genomics in the discovery of novel targets for antibiotic therapy.
    Ji Y
    Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics in anti-infective drug discovery--getting to endgame.
    Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ
    Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial genomics and novel antibiotic discovery: new technology to search for new drugs.
    Dougherty TJ; Barrett JF; Pucci MJ
    Curr Pharm Des; 2002; 8(13):1119-35. PubMed ID: 12052223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of genomics on novel antibacterial targets.
    Payne DJ; Wallis NG; Gentry DR; Rosenberg M
    Curr Opin Drug Discov Devel; 2000 Mar; 3(2):177-90. PubMed ID: 19649849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.